Document Detail

Topical therapy for the management of childhood psoriasis: part I.
MedLine Citation:
PMID:  18506356     Owner:  NLM     Status:  MEDLINE    
Psoriasis represents a potentially life-altering disease that can profoundly impact physical, emotional and social functioning, and overall quality of life. The majority of cases are mild and managed adequately with topical medications. A minor subset of children present with severe, rapidly evolving disease that requires systemic therapy. The choice of treatment in children, as in adults, is determined by disease acuity, morphology, distribution, severity and the presence of comorbidities such as psoriatic arthropathy. Practical considerations such as ease of use, patient acceptability, accessibility, risk to benefit ratio, cost and individual perceptions of disease and quality of life are factored into treatment decisions. Part I of this 2-part series will focus on topical agents, their varying degrees of effectiveness, potential side-effects and applications in clinical practice.
K M Cordoro
Related Documents :
10472576 - Late cardiotoxicity of anthracyclines in children with acute leukemia.
18506356 - Topical therapy for the management of childhood psoriasis: part i.
9926516 - Pemphigus vulgaris.
17990336 - Prevalence of down syndrome among children and adolescents in metropolitan atlanta.
10923606 - Prevalence of asthma, allergic rhinitis, and eczema in 13- to 14-year-old children in k...
11737836 - Perception of chloroquine efficacy and alternative treatments for uncomplicated malaria...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Skin therapy letter     Volume:  13     ISSN:  1201-5989     ISO Abbreviation:  Skin Therapy Lett.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-05-28     Completed Date:  2008-07-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9891441     Medline TA:  Skin Therapy Lett     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  1-3     Citation Subset:  IM    
Department of Dermatology, University of California, San Francisco, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Cutaneous
Dermatologic Agents / adverse effects,  therapeutic use*
Glucocorticoids / adverse effects,  therapeutic use*
Keratolytic Agents / adverse effects,  therapeutic use*
Psoriasis / drug therapy*
Reg. No./Substance:
0/Dermatologic Agents; 0/Glucocorticoids; 0/Keratolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Social support and social network in family nursing: reviewing concepts.
Next Document:  Advances in pemphigus therapy.